Shen et al. investigated the association between COX2 genetic variation, use of NSAIDs, and breast cancer risk, providing modest evidence that the C allele of COX2.8473 may interact with NSAIDs to reduce risk for hormone receptor-positive breast cancer. The gene discussed is PTGS2; the disease is breast carcinoma.